Donald Trump's latest tariff deadline arrives tonight, with potential new duties on America's top three trading partners starting tomorrow morning. The promises could match or surpass the economic ...

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on during any economic environment. This is because patients need their ...

I had a very bearish outlook on KSS and expected that it would face higher input costs, lower consumer retail demand, and a rise in interest costs after its 2023 debt maturities. However ...

This week's earnings include retailers like Dick’s Sporting Goods, Dollar General, and Kohl’s. Investors will look for Feb. CPI reading that is due Wednesday. See more.

It's also a term that gets MarketBeat Kohl's Slashes 10% Corporate Jobs, Names New CEO Kohl's Inc. (NYSE: KSS) is cutting around 10% of its corporate workforce, impacting fewer than 400 roles ...

Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in a third major transaction announced on the first day of the JP Morgan ...

US stocks managed to finish the week on a positive note after a volatile session following a weaker-than-expected jobs report and comments from the head of the Federal Reserve, who said policymakers ...

Eli Lilly has raised its revenue guidance for 2024 by $3 billion, after reporting strong growth for tirzepatide in diabetes and obesity, fuelled by the end of supply constraints for starting doses.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - March 10 ...